In a clinical trial with PEGINTRON™/REBETOL® (Ribavirin, USP) Capsules combination therapy, 52% of patients achieved SVR. Scroll below for Important Safety Information and Prescribing Information.

Maybe you've been Recently Diagnosed with hepatitis C. Or maybe you're already being treated by Taking PEGINTRON™. In either case, living with hepatitis C isn't easy and you don't have to go it alone. You've come to the right source to get the knowledge and support that you need.

Get started by browsing Treatment & Me. Read Why PEGINTRON™ offers a low relapse rate. Most importantly, stay committed to your treatment. There's plenty of caring Support & Assistance to help you along the way.

The information provided on this site is not intended to be a substitute for professional medical advice. Please consult your health care provider directly with any question you may have regarding your health, condition, or treatment. Your health care provider should be your primary source of information regarding your medical condition and treatment.